VTGN
Vistagen Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Vistagen Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Vistagen Therapeutics, Inc.
0.17
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Commodore CapitalCommodore Capital | $630,228 | 21.39% | new | |
| 2 | Vanguard Capital ManagementVanguardindex-like | $355,769 | 12.07% | 0.00% | |
| 3 | Two Sigma InvestmentsTwo Sigma | $191,646 | 6.50% | +80.57% | |
| 4 | Acadian Asset ManagementAcadian | $180,000 | 6.11% | +34.75% | |
| 5 | Renaissance TechnologiesRenaissance Technologies | $165,093 | 5.60% | +150.77% | |
| 6 | StemPoint CapitalStemPoint Capital | $139,000 | 4.72% | 0.00% | |
| 7 | Ikarian CapitalIkarian Capital | $117,311 | 3.98% | 0.00% | |
| 8 | Susquehanna International GroupSusquehanna International | $105,731 | 3.59% | +151.19% | |
| 9 | AdvisorShares InvestmentsAdvisorShares | $99,133 | 3.36% | +58.29% | |
| 10 | Luminus ManagementLuminus | $91,104 | 3.09% | +1.78% | |
| 11 | Geode Capital ManagementGeodeindex-like | $82,514 | 2.80% | −19.50% | |
| 12 | ADAR1 Capital ManagementADAR1 | $79,358 | 2.69% | −53.25% | |
| 13 | BlackRockBlackRockindex-like | $78,068 | 2.65% | −22.98% | |
| 14 | Millennium ManagementMillennium | $69,292 | 2.35% | −52.42% | |
| 15 | Group One TradingGroup One Trading | $68,791 | 2.33% | +1431.50% | |
| 16 | Verdad AdvisersVerdad | $66,296 | 2.25% | +58.62% | |
| 17 | Jane Street GroupJane Street | $60,077 | 2.04% | −10.20% | |
| 18 | Citadel AdvisorsCitadel | $52,645 | 1.79% | −15.26% | |
| 19 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $49,200 | 1.67% | 0.00% | |
| 20 | Tudor Investment Corp ET ALTudor Investment Corp ET AL | $37,742 | 1.28% | +57.29% | |
| 21 | Boothbay Fund ManagementBoothbay Fund | $30,413 | 1.03% | 0.00% | |
| 22 | State StreetState Streetindex-like | $27,372 | 0.93% | 0.00% | |
| 23 | XTX TopcoXTX Topco | $26,754 | 0.91% | −22.55% | |
| 24 | Northern TrustNorthern Trustindex-like | $18,266 | 0.62% | +11.24% | |
| 25 | Virtu FinancialVirtu Financial | $15,000 | 0.51% | new |
48 managers report $2.9M of Vistagen Therapeutics on form 13F for the quarter ended Jun 30 '26. 14 of them hold 80% of it; Commodore Capital is largest at 21.39%.
No implied move.
No implied move.
Expected move
No implied move.